Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Insulet Corp

PODD ✓ COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Medical Equipment, Supplies & Distribution ·

USA Large Cap Analyst: BUY

Last Close

$148.16

▲ +0.88%

Market Cap $10.28B · Vol 330.49K

Key Metrics

P/E Ratio

27.71

FWD: 20.60

Market Cap

$10.28B

Large Cap

Div Yield

N/A

EPS Growth

+29.98%

YoY

RSI (14)

35.47

Momentum

Beta

1.08

vs Market

52W High

$354.87

58.25% below

52W Low

$126.50

17.12% above

Volume

330.49K

Avg 506.09K

P/B

13.20

Price-to-book

ROE

26.21%

Return on equity

Free Float

99.65%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Insulet Corp (PODD) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does PODD pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+3.36%

-9.50%

-5.56%

-38.75%

YTD

-47.88%

-54.81%

-25.07%

-49.82%

Financials & Valuation

TTM · Annual

Total Revenue	$2.71B
Net Income	$247.10M
Revenue Growth (YoY)	+23.51%
Gross Margin	71.63%
Operating Margin	17.84%
Net Profit Margin	9.12%
ROE	26.21%
ROA · ROIC	10.82% · 11.42%

P/E Ratio	27.71
Forward P/E (FY1)	20.60
PEG Ratio	-2.05
P/S	7.55
P/B	13.20
P/FCF	58.41
EPS Growth	+29.98%
Outstanding Shares	69.35M

Technical Indicators

50-Day SMA	$154.44
200-Day SMA	$219.16
RSI (14)	35.47
Beta	1.08
52-Week High	$354.87
52-Week Low	$126.50

Volume Today	330.49K
Avg Daily Volume (30D)	506.09K
Relative Volume	0.65x
Volatility (10D)	39.45
Volatility (30D)	73.83
Free Float	99.65%

Analyst Consensus

BUY

Current Price $148.16

Mean Target $183.87

52W Low$126.50 52W High$354.87

Current

Target

$126.50 $354.87

Current Analyst target

+24.10% upside potential · 27 analysts

Identifiers

ExchangeNasdaq

FIGIBBG001SRF439

ISINUS45784P1012

CountryUnited States of America

Sub-IndustryMedical Equipment, Supplies & Distribution (NEC)

Earnings DateNov 4, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

ABT Abbott Laboratories +2.19% MDT Medtronic PLC +1.14% COR Cencora Inc +1.06% 7741.T Hoya Corp -1.37% BDX Becton Dickinson and Co +2.33%

Company Profile

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.